Clinico-characteristics of patients which correlated with preferable treatment outcomes in immunotherapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis

BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is the third-most lethal malignant tumor worldwide. The rapid development of immunotherapy utilizing immune checkpoint inhibitors for advanced HCC patients has been witnessed in recent years, along with numerous randomized clinical trials demonstra...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yani, Lau, Wanyee, Li, Yafei, Tian, Yichen, Lei, Yongrong, Wang, Jianhua, Xia, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651248/
https://www.ncbi.nlm.nih.gov/pubmed/37598406
http://dx.doi.org/10.1097/JS9.0000000000000652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651248/
https://www.ncbi.nlm.nih.gov/pubmed/37598406
http://dx.doi.org/10.1097/JS9.0000000000000652

Ejemplares similares